In a 20-year-old with three weeks of a mildly wet cough that worsens on deep inspiration and a history of reactive airway disease, what medications should be added besides an albuterol inhaler?

Add an Inhaled Corticosteroid (ICS)

For this 20-year-old with 3 weeks of persistent cough and reactive airway disease, you should prescribe an inhaled corticosteroid (ICS) in addition to the albuterol inhaler. This represents cough-variant asthma or asthmatic cough, which requires anti-inflammatory therapy as the cornerstone of treatment 1.

Rationale for ICS Therapy

The 3-week duration makes this a chronic cough (>3 weeks), and the history of reactive airway disease with cough triggered by deep inspiration strongly suggests asthmatic cough. The ACCP guidelines explicitly state that patients with cough due to asthma should initially be treated with a standard antiasthmatic regimen of inhaled bronchodilators AND inhaled corticosteroids 1. Albuterol alone addresses only the bronchospasm component but does nothing for the underlying airway inflammation driving the persistent cough.

Key Clinical Points:

• Cough-variant asthma presents with cough as the predominant or sole symptom, without wheezing or dyspnea 1
• The slightly wet quality doesn't exclude asthma—asthmatic cough can produce minimal sputum
• Three weeks of symptoms indicates this is beyond a simple viral upper respiratory infection
• Deep breath triggering cough suggests airway hyperreactivity

Specific Treatment Recommendation

Start a low-to-medium dose ICS (such as budesonide 180-360 mcg twice daily, fluticasone 88-220 mcg twice daily, or equivalent) along with the albuterol as needed 1, 2.

If No Response to ICS + Albuterol:

The guidelines provide a clear escalation pathway 1:

1. First escalation: Add a leukotriene receptor antagonist (LTRA) like montelukast 10 mg daily before moving to systemic steroids 1

2. For severe/refractory cases: Consider a short course (1-2 weeks) of oral corticosteroids (prednisone 40-60 mg daily) followed by continuation of ICS 1

What NOT to Add

Do NOT add ipratropium bromide at this stage. While the asthma guidelines mention ipratropium for acute exacerbations 3, this patient is not having an acute severe exacerbation—she has chronic cough. The prehospital study showed no benefit of adding ipratropium to albuterol for reactive airway disease 4, and it's not part of the recommended initial regimen for chronic asthmatic cough 1.

Common Pitfalls to Avoid

• Don't treat with albuterol alone—this only provides temporary symptom relief without addressing the inflammatory component, allowing the cough to persist
• Don't assume the wet quality means bacterial infection—asthmatic cough can produce some sputum, and antibiotics are not indicated here
• Don't delay ICS therapy waiting to see if albuterol alone works—the guidelines are clear that both should be started together for asthmatic cough 1

Follow-up Plan

Schedule reassessment in 2-4 weeks to evaluate response. The cough should improve within this timeframe if asthma is the cause. If no improvement despite good ICS compliance, consider:

• Assessing for other causes (GERD, post-nasal drip, non-asthmatic eosinophilic bronchitis)
• Adding LTRA before escalating to oral steroids 1
• Confirming diagnosis with methacholine challenge if available 1